The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African Women

Lignende værker

• HIV Pre-exposure Prophylaxis (PrEP) in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-effectiveness
  af: Paltiel, A. David, et al.
  Udgivet: (2009)
• Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
  af: Walensky, Rochelle P., et al.
  Udgivet: (2016)
• The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy
  af: Ross, Eric L., et al.
  Udgivet: (2015)
• Misinterpretation of HIV Preexposure Prophylaxis Findings
  af: Paltiel, A. David, et al.
  Udgivet: (2014)
• Comparative pricing of branded tenofovir alafenamide/emtricitabine relative to generic tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: A cost-effectiveness analysis
  af: Walensky, Rochelle P., et al.
  Udgivet: (2020)